Life360 Inc
ASX:360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Life360 Inc
ASX:360
|
US |
|
Bunge Global SA
F:Q23
|
US |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
Wall St Price Targets
Price Targets Summary
Life360 Inc
According to Wall Street analysts, the average 1-year price target for Life360 Inc is 31.35 AUD with a low forecast of 19.82 AUD and a high forecast of 38.63 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Life360 Inc's stock price target?
Price Target
31.35
AUD
According to Wall Street analysts, the average 1-year price target for Life360 Inc is 31.35 AUD with a low forecast of 19.82 AUD and a high forecast of 38.63 AUD.
What is the Revenue forecast for Life360 Inc?
Projected CAGR
14%
Over the last 3 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 8 years is 14%.
What is the Operating Income forecast for Life360 Inc?
Projected CAGR
57%
The compound annual growth rate for Operating Income over the next 8 years is 57%.
What is the Net Income forecast for Life360 Inc?
Projected CAGR
-14%
The compound annual growth rate for Net Income over the next 3 years is -14%.
